BusinessVisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)By Nasdaq OMXApr 16, 2018, 1:23 PM UTC
BusinessVisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018By Nasdaq OMXApr 12, 2018, 5:46 PM UTC
BusinessInspirata Establishes London Office to Support Pan-European Operations for Newly Acquired Omnyx® Digital Pathology Software and its Workflow SolutionBy Nasdaq OMXApr 3, 2018, 3:25 PM UTC
BusinessPrecipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy PlatformBy Nasdaq OMXMar 20, 2018, 11:37 AM UTC
BusinessKey Measure of Precipio’s Pathology Sales Growth 4X Prior QuarterBy Nasdaq OMXFeb 22, 2018, 1:39 PM UTC
BusinessPrecipio Launches Unique Lung Cancer Monitoring Test for Therapy ResistanceBy Nasdaq OMXFeb 15, 2018, 1:38 PM UTC
BusinessPrecipio Announces Q4 2017 Revenue at 350% of Previous QuarterBy Nasdaq OMXFeb 9, 2018, 2:00 PM UTC
